Article
Metabolic reprogramming in mutant IDH1 glioma cells.
PloS one - 1 Jan 2015
Izquierdo-Garcia Jose L, Viswanath Pavithra, Eriksson Pia, Chaumeil Myriam M, Pieper Russell O, Phillips Joanna J, Ronen Sabrina M
Abstract excerpt
BACKGROUND: Mutations in isocitrate dehydrogenase (IDH) 1 have been reported in over 70% of low-grade gliomas and secondary glioblastomas. IDH1 is the enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate while mutant IDH1 catalyzes the conversion of α-ketoglutarate into 2-hydroxyglutarate. These mutations are associated with the accumulation of 2-hydroxyglutarate within the tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
